EUVIMEDEUVIMED entdecken
Crossref

Targeting multidrug-resistant Acinetobacter baumannii with pyrazole therapeutics: The role of clinical microbiology and structure–activity relationship (SAR) insights

Kamal Kamal

Journal of Clinical and Experimental Reproductive Medicine · 26.11.2025 · 1 (2) · 13

DOI: 10.46439/reproductivemed.2.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Reproductive Medicine, online erschienen am 26.11.2025. Verfasst von Kamal Kamal. Die Arbeit nennt 72 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating prevalence of multidrug-resistant (MDR) Acinetobacter baumannii presents a formidable challenge to global healthcare, necessitating innovative therapeutic strategies. This review explores the critical role of clinical microbiology in the detection, surveillance, and management of MDR A. baumannii infections, underscoring the importance of accurate diagnostics and infection control. Concurrently, the pyrazole heterocyclic scaffold emerges as a promising molecular framework in the development of novel antibacterial agents, owing to its versatile chemical properties and demonstrated bioactivity against resistant strains. MDR A. baumannii has emerged as a major global health threat, with prevalence rates exceeding 60% in many hospital-acquired infections, thereby underscoring the urgent need for novel therapeutic approaches. This review provides a comprehensive analysis of recent advances in the development of pyrazole-based scaffolds, emphasizing structure-activity relationship (SAR) insights that rational design and fine-tuning of antibacterial potency and target selectivity. This integrated perspective highlights the synergy between clinical microbiological approaches and medicinal chemistry advancements, contributing to the design of more effective antimicrobial agents against the increasingly resistant and clinically significant pathogen A. baumannii.

Zitieren

APA

Kamal, K. (2025). Targeting multidrug-resistant Acinetobacter baumannii with pyrazole therapeutics: The role of clinical microbiology and structure–activity relationship (SAR) insights. Journal of Clinical and Experimental Reproductive Medicine, 1(2), 13. https://doi.org/10.46439/reproductivemed.2.008

Vancouver

Kamal K. Targeting multidrug-resistant Acinetobacter baumannii with pyrazole therapeutics: The role of clinical microbiology and structure–activity relationship (SAR) insights. Journal of Clinical and Experimental Reproductive Medicine. 2025;1(2):13. doi:10.46439/reproductivemed.2.008

BibTeX
@article{Kamal2025,
  author = {Kamal, Kamal},
  title = {Targeting multidrug-resistant Acinetobacter baumannii with pyrazole therapeutics: The role of clinical microbiology and structure–activity relationship (SAR) insights},
  journal = {Journal of Clinical and Experimental Reproductive Medicine},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {13},
  doi = {10.46439/reproductivemed.2.008}
}
Kostenlos starten →